Literature DB >> 30100569

Levosulpiride-induced neuroleptic malignant syndrome in rheumatoid arthritis.

Devashish Desai1, Kartik Gupta1, Rohit Kumar1, Ashutosh Biswas1.   

Abstract

A 53-year-old woman, known case of diabetes mellitus and rheumatoid arthritis, presented with a 4-day history of hyperthermia, rigidity, tremor and altered sensorium. She developed these symptoms after having been administered parenteral levosulpiride to control vomiting due to secondary adrenal insufficiency. We managed her as a case of life-threatening neuroleptic malignant syndrome (NMS) requiring mechanical ventilation, bromocriptine and other supportive care. She subsequently recovered and was discharged in a stable condition. To the best of our knowledge, this is the first documented case report describing levosulpiride-induced NMS. © BMJ Publishing Group Limited 2018. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  drug misuse (including addiction); gastrointestinal system; unwanted effects / adverse reactions

Mesh:

Substances:

Year:  2018        PMID: 30100569     DOI: 10.1136/bcr-2018-224679

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  2 in total

1.  Neuroleptic malignant syndrome in a patient with moderate intellectual disability treated with olanzapine: A case report.

Authors:  Francesco Piacenza; Suet Kee Ong; Patrick O'Brien; Maurice Clancy
Journal:  Clin Case Rep       Date:  2021-03-15

2.  Neuroleptic malignant syndrome secondary to olanzapine, a presentation with severe acute kidney injury requiring hemodialysis: a case report.

Authors:  Chee Keong Chang; Alvin Oliver Payus; Malehah Mohd Noh; Meryl Grace Lansing; Doreen Sumpat; Sooth Jiun Andrea Lu; Boon Teong Yew
Journal:  J Med Case Rep       Date:  2022-10-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.